001     132865
005     20240229105036.0
024 7 _ |a 10.1038/leu.2017.346
|2 doi
024 7 _ |a pmid:29209043
|2 pmid
024 7 _ |a 0887-6924
|2 ISSN
024 7 _ |a 1476-5551
|2 ISSN
024 7 _ |a altmetric:30133918
|2 altmetric
037 _ _ |a DKFZ-2018-00508
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Tirado-Gonzalez, I.
|b 0
245 _ _ |a CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC.
260 _ _ |a Basingstoke
|c 2018
|b Nature Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1677758403_19619
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Czlonka, E.
|b 1
700 1 _ |a Nevmerzhitskaya, A.
|b 2
700 1 _ |a Soetopo, D.
|b 3
700 1 _ |a Bergonzani, E.
|b 4
700 1 _ |a Mahmoud, Mohamed Abdalla Abdelaziz
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Contreras, A.
|b 6
700 1 _ |a Jeremias, I.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Platzbecker, U.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Bourquin, J. P.
|b 9
700 1 _ |a Kloz, Ulrich
|0 P:(DE-He78)1a5f84c92367a0ab8dffdd2d3619e234
|b 10
700 1 _ |a van der Hoeven, Franciscus
|0 P:(DE-He78)db41d10e17712fc21628c50a14f4d507
|b 11
700 1 _ |a Medyouf, Hind
|0 P:(DE-He78)67eaeecc9d8e4f52f6eee0e857ee215c
|b 12
773 _ _ |a 10.1038/leu.2017.346
|g Vol. 32, no. 4, p. 1049 - 1052
|0 PERI:(DE-600)2008023-2
|n 4
|p 1049 - 1052
|t Leukemia
|v 32
|y 2018
|x 1476-5551
909 C O |p VDB
|o oai:inrepo02.dkfz.de:132865
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)1a5f84c92367a0ab8dffdd2d3619e234
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)db41d10e17712fc21628c50a14f4d507
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)67eaeecc9d8e4f52f6eee0e857ee215c
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Addenda
|x 0
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LEUKEMIA : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b LEUKEMIA : 2015
920 1 _ |0 I:(DE-He78)L701-20160331
|k L701
|l DKTK München
|x 0
920 1 _ |0 I:(DE-He78)L301-20160331
|k L301
|l DKTK Dresden
|x 1
920 1 _ |0 I:(DE-He78)L501-20160331
|k L501
|l DKTK Frankfurt
|x 2
920 1 _ |0 I:(DE-He78)W450-20160331
|k W450
|l Gruppe van der Hoeven
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)L701-20160331
980 _ _ |a I:(DE-He78)L301-20160331
980 _ _ |a I:(DE-He78)L501-20160331
980 _ _ |a I:(DE-He78)W450-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21